Phreesia, Inc. (LON:0A23)
London · Delayed Price · Currency is GBP · Price in USD 28.50
-0.54 (-1.86%)
At close: Jan 31, 2025
Phreesia Market Cap
Phreesia has a market cap or net worth of 1.31 billion as of August 22, 2025. Its market cap has increased by 26.99% in one year.
Market Cap
1.31B
Enterprise Value
1.25B
Revenue
325.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.50
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from 706.60M to 1.31B, an increase of 85.05%. That is a compound annual growth rate of 10.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 1.27B | 9.10% |
| Dec 31, 2024 | 1.17B | 15.52% |
| Dec 29, 2023 | 1.01B | -28.62% |
| Dec 30, 2022 | 1.42B | -10.14% |
| Dec 31, 2021 | 1.58B | -10.18% |
| Dec 31, 2020 | 1.76B | 143.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.59B |
| GSK plc | 60.14B |
| Haleon | 32.68B |
| Smith & Nephew | 12.07B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.00B |